COMPLETED
Antibody protection for chronic enteric diseases
PAnACEA — Protezione di un Anticorpo mediante Alginato per la Cura di patologie Enteriche ad Andamento cronico
PAnACEA investigated an innovative approach for chronic enteric diseases based on the protection of an antibody through alginate-based delivery.
The project combined antibody formulation and protection with experimental evaluation of the proposed therapeutic approach.
Programme
Anticipation PR FESR 2021–2027 — Friuli Venezia Giulia Region
MTTlab role
In Vivo Preclinical Research
MTTlab contribution
MTTlab was responsible for the in vivo phase of the project, evaluating the proposed therapeutic approach in an experimental model of ulcerative colitis.